Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism
This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty
 adolescents. Subjects who complete this trial may enter a 3 month extension study
 (UMD-01-090E).
Inclusion Criteria:

 -  Primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP)

 Exclusion Criteria:

 -  Skin intolerance to alcohol or allergy to soy

 -  Generalized skin disease

 -  Contraindication to testosterone or androgen products